•
Mar 31, 2021

Seres Therapeutics Q1 2021 Earnings Report

Total Revenue
$5.72M
Previous year: $8.19M
-30.2%
EPS
-$0.39
Previous year: -$0.28
+39.3%
Gross Profit
-$23.6M
Cash and Equivalents
$66.6M
Free Cash Flow
-$30.8M
Total Assets
$306M

Seres Therapeutics

Seres Therapeutics